Company Overview

Update
Headquarters:
Cambridge
Funding:
$4.70M
Categories:
Biotechnology

Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.

Description

Update

Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programmes. The Company’s proprietary production platform OptiDIFF robustly generates human cell types including liver hepatocytes using hIPSC human Induced Pluripotent Stem Cell technology.

Funding Rounds (3) - $4.70M

Update

Investors (1)

Update
  • 8f2862fa093b7f813543a4df93a8ce62

    Parkwalk Advisors Ltd

    Parkwalk is an investment management firm focused on UK-based technology companies.

Offices/Locations (1)

Update
  • Office

    Babraham Research Campus

    Babraham

    Cambridge, CB22 3AT

    GBR

Images (1)

Update
  • 34af3db8775a987af1b74b3d64ae0b31